CPP Bone Infection team receives the CORR® ORS Richard A Brand Award for Outstanding Orthopaedic Research
The prompt and reliable diagnosis of bone infection is a critical first step in the successful treatment of an infection. In 2015, a team of researchers within the AO Trauma Research Clinical Priority Program (CPP) Bone Infection received the Richard A Brand Award for Outstanding Orthopaedic Research for the manuscript entitled “A multiplex assay of host immunity against Staphylococcus aureus for osteomyelitis patients” (Nishitani et al, 2015). The award serves to promote, support, develop, and encourage research, educational activities, and knowledge dissemination in surgery, musculoskeletal disease, and related disciplines.
The work involves a serological assay that enables detection of Staphylococcus aureus-specific antibody responses in the blood, promising to improve infection diagnosis in patients.
- Daiss JL, Kates SL, Schwarz EM. Diagnosis and monitoring of ongoing Staphylococcus aureus infections using circulating antibody-secreting cells. Submitted to CMSR P30 Pilot Program March 2014. Awarded July 1, 2014.
- Soin S, Daiss JL, Kates SL. A novel approach to bacterial diagnostics: utilizing circulating plasmablasts to diagnose orthopaedic Staphylococcus aureus infections. AOTNA Research Resident Fellowship Award. Submitted September 2014. Awarded November 4, 2014.
- Daiss JL. Diagnosis of early Staphylococcus aureus infections using circulating plasmablasts. Submitted to NIH October 2014. Application #1R21AI119646-01. $275,000.
- Oh I, Daiss JL, Gill S. Clinical applicability of using circulating antibody-secreting cells for assessments of treatment response and prognosis of active Staphylococcus aureus infections in diabetic foot. Goldstein Award, awarded May 2015.